Neonatal meningitis caused by Streptococcus gallolyticus subsp. pasteurianus

Journal of Infection and Chemotherapy

Volumn 18, Issue 2, 2012, Pages 265-268

  Nagamatsu, Maki ^a   Takagi, Taeko ^a   Ohyanagi, Tadatomo ^a   Yamazaki, Satoshi ^a   Nobuoka, Sachihiko ^a   Takemura, Hiromu ^a   Akita, Hironobu ^b   Miyai, Mitsuo ^c   Ohkusu, Kiyofumi ^d  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY   (Japan)

^c YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^d GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Meningitis; Streptococcus bovis group; Streptococcus gallolyticus subsp. pasteurianus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; C REACTIVE PROTEIN; CEFDITOREN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOTIAM; CEFOZOPRAN; CEFTRIAXONE; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; DEXAMETHASONE; DIAZEPAM; ERYTHROMYCIN; IMMUNOGLOBULIN; LEVOFLOXACIN; MANNITOL; MEROPENEM; MIDAZOLAM; PANIPENEM; PANIPENEM PLUS BETAMIPRON; PENICILLIN G; PHENYTOIN; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

16S RRNA GENE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BRAIN EDEMA; CASE REPORT; CLONIC SEIZURE; CYANOSIS; DETERIORATION; DRUG DOSE REDUCTION; GRAM STAINING; HUMAN; IRRITABILITY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; PROTEIN CEREBROSPINAL FLUID LEVEL; RNA GENE; SEIZURE; STREPTOCOCCUS; STREPTOCOCCUS GALLOLYTICUS PASTEURIANUS;

EID: 84863318885     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0320-4     Document Type: Article

References (17)

1. Ellmerich S, Scholler M, Duranton B, Gosse F, Galluser M, Klein JP, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis (Oxf). 2000;21:753-6.
2. Schlegel L, Grimont F, Ageron E, Grimont PAD, Bouvet A. Reappraisal of the taxonomy of the Streptococcus bovis/Streptocccus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol. 2003;53:631-45.
3. Nagai K, Gotoh K, Hirotaki S, Hidaka H, Koga H, Ikenaga M, et al. A case of bacterial meningitis due to Streptococcus bovis in an infant with normal cerebrospinal fluid findings at the first CSF examination. Kansenshogaku Zasshi. 2008;82:26-9.
4. Grant RJ, Whitehead TR, Orr JE. Streptococcus bovis meningitis in an infant. J Clin Microbiol. 2000;38:462-3.
5. Gavin PJ, Thompson Jr RB, Horng SJ, Yogev R. Neonatal sepsis caused by Streptococcus bovis variant (biotype II/2): report of a case and review. J Clin Microbiol. 2003;41:3433-5.
6. Lee RA, Woo PCY, To APC, Lau SK, Wong SSY, Yuen KY. Geographical difference of disease association in Streptococcus bovis bacteraemia. J Med Microbiol. 2003;52:903-8.
7. Herrero IA, Rouse MS, Piper KE, Alyaseen SA, Steckelberg JM, Patel R. Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysis. J Clin Microbiol. 2002;40:3848-50.
8. Beck M, Frodl R, Funke G. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol. 2008;46:2966-72.
9. Clarridge JE III, Attorri SM, Zhang Q, Bartell J. 16S ribosomal DNA sequence analysis distinguishes biotypes of Streptococcus bovis: Streptococcus bovis biotype II/2 is a separate genospecies and the predominant clinical isolate in adult males. J Clin Microbiol. 2001;39:1549-52.
10. Kawamura Y. Taxonomic changes of the genera Staphylococcus and Streptococcus on this decade. Modern Media. 2005;51: 313-27.
11. Ubukata K, Chiba N, Hasegawa K, Kobayashi R, Iwata S, Sunakawa K. Antibiotic susceptibility in relation to penicillinbinding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother. 2004;48:1488-94.
12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20. CLSI; 2010.
13. Sunakawa K, Ubukata K, Chiba N, Hasegawa K, Nonoyama M, Iwata S, et al. Childhood bacterial meningitis trends in Japan from 2005 to 2006. Kansenshogaku Zasshi. 2008;82:187-97.
14. Onoyama S, Ogata R, Wada A, Saito M, Okada K, Harada T. Neonatal bacterial meningitis caused by Streptococcus gallolyticus subsp. pasteurianus. J Clin Microbiol. 2009;58:1252-4.
15. Steux R, Dubois D, Bonnet R, Jacquetin B, Hennequin C. Streptococcus anginosus and Streptococcus gallolyticus subsp. pasteurianus chorioamniotitis. Med Mal Infect. 2008;38:507-9.
16. Akahane T, Takahashi K, Matsumoto T, Kawakami Y. A case of peritonitis due to Streptococcus gallolyticus subsp. pasteurianus. Kansenshogaku Zasshi. 2009;83:56-9.
17. Hoogkamp-Korstanje JA, Roelofs-Willemse J. Comparative in vitro activity of moxifloxacin against gram-positive clinical isolates. J Antimicrob Chemother. 2000;45:31-9.